Ligand Pharm (LGND)
$113.55
1.33 (1.16%)
LGND Stock Quote Delayed 15 Minutes
Previous Close
$114.88
Market Cap
2.42B
PE Ratio
53.06
EPS
2.14
Volume (Avg. Vol.)
207,211
Day's Range
113.53 - 116.50
52-Week Range
98.56 - 278.62
Dividend & Yield
N/A (N/A)
LGND Stock Predictions, Articles, and Ligand Pharm News
Best ETFs for 2018: Don’t Sweat This Quarter for the SBIO ETF
On a year-to-date basis, SBIO still looks good, up 14.30%, or 310 basis points better than the Nasdaq Biotechnology Index. Year-to-date, SBIO is also outpacing the equal-weight S&P Biotechnology Select Industry Index.
5 Biotech Stocks to Boost Your Portfolio’s Health This Year
Though the biotech industry is down this year, there are still a few stocks which can strengthen your portfolio. Compare Brokers....
24 Biotechnology Stocks to Sell Now
This week, the ratings of 24 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Biggest Movers in Manufacturing Stocks Now – KTOV JUNO CCXI CARA
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
4 Biotechnology Stocks to Buy Now
The grades of 4 Biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
Biggest Movers in Manufacturing Stocks Now – NTLA CTRL PRCP MNTA
The following stocks were moving the Manufacturing sector today.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
F
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
